bradyarrhythmia
Conditions
Interventions
None listed
Sponsors
National Cerebral and Cardiovascular Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who provided written informed consent for study participation of their own free will. 2) Patients aged 18 years or older but under 80 years at the time of consent acquisition. 3) Patients with any of the following bradyarrhythmias: Sinus node dysfunction: Type I, Type II. Atrioventricular block: First degree, Second degree or high-grade, and Third degree. Bradyarrhythmic atrial fibrillation. 4) Patients with any of the following symptoms caused by bradyarrhythmia: Fatigue, shortness of breath, decreased exercise tolerance, dizziness, lightheadedness, syncope, falls, dyspnea, chest pain, nausea, psychological burden due to the above symptoms.
Exclusion criteria
Exclusion criteria: 1) Patients with the following conditions or a history thereof: Moderate or severe aortic valve or mitral valve disease. Thyroid dysfunction. Ischemic heart disease (including myocardial infarction). Myocardial diseases such as cardiomyopathy. Patients with currently active malignant tumors or those who completed treatment for malignant tumors less than 5 years ago. 2) Patients with active infections requiring systemic treatment. 3) Patients with psychiatric disorders that pose problems for follow-up or compliance with the study protocol. 4) Other patients deemed inappropriate by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in various quality of life indices before and after pacemaker implantation. | — |
Countries
Japan
Contacts
Public ContactYoshihiro Asano
National Cerebral and Cardiovascular Center Genome Medicine Support Department
Outcome results
None listed